SCHEMBL22567057

SCHEMBL22567057

N#Cc1cccc(-c2cc(-c3ccccc3)c(-c3ccccc3)cn2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRG2 P18507 3/20 0.54
▸ GABRB3 P28472 3/20 0.54
▸ GABRA5 P31644 3/20 0.54
▸ GABRA3 P34903 3/20 0.54
▸ GABRA1 P14867 1/20 0.54
▸ IDO1 P14902 2/20 0.53
▸ CLK4 Q9HAZ1 2/20 0.51
▸ GRM5 P41594 4/20 0.51
▸ CYP1A2 P05177 2/20 0.51
▸ CYP2C19 P33261 2/20 0.51
▸ USP2 O75604 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ KDM1A O60341 1/20 0.50
▸ MAOB P27338 1/20 0.49
▸ ATR Q13535 2/20 0.48
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31384802 0.82 GABRG2 (0.52) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL5653453 0.78 NPC1 (0.50) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL3422474 0.77 ADRA2C (0.60) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL31272452 0.77 ADRA2C (0.60) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL9792939 0.76 CLK4 (0.62) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL10431256 0.76 GABRA1 (0.59) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL16016610 0.75 GABRG2 (0.63) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL385924 0.75 ATR (0.62) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL1133442 0.75 CLK4 (0.66) IDO1CLK4GRM5ALDH1A1TSHR
SCHEMBL29472032 0.75 CLK4 (0.66) IDO1CLK4GRM5ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220209141-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2022-06-30 — — US disclosed
WO-2020212296-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2020-10-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220209141-A1 METAL COMPLEXES AP1M1, SOD1, AP3M1 GABRG2 2314/4885GABRB3 2117/4885GABRA5 2149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback